Deborah Ramsdell

Directeur Général chez Valerion Therapeutics LLC

Profil

Deborah Ramsdell currently works at Valerion Therapeutics LLC, as President, Chief Executive Officer & Director from 2013, Orphan Technologies Ltd., as Director from 2015, Phoenicis Therapeutics, Inc., as President, Treasurer & Director, and Alopexx Enterprises LLC, as VP-Development Operations & Regulatory Affairs from 2011.
Ms. Ramsdell also formerly worked at Wings Therapeutics, Inc., as President & Chief Executive Officer, ImmunoGen, Inc., as Director-Regulatory Affairs & Quality Assurance, Virus Research Institute, Inc., as Director-Regulatory Affairs & Quality Assurance, Biotechnica International, Inc., as Principal, Alexion Pharmaceuticals, Inc., as VP-Regulatory Affairs & Clinical Operations, and Enobia Pharma, Inc., as VP-Regulatory Affairs & Clinical Operations.
Ms. Ramsdell received her undergraduate degree and graduate degree from Boston College.

Postes actifs de Deborah Ramsdell

Sociétés	Poste	Début
Valerion Therapeutics LLC	Directeur Général	-
Alopexx Enterprises LLC	Conseiller Juridique Général	01/01/2011
Phoenicis Therapeutics, Inc.	President	-

Anciens postes connus de Deborah Ramsdell

Sociétés	Poste	Fin
Orphan Technologies Ltd.	Directeur/Membre du Conseil	14/10/2022
Wings Therapeutics, Inc.	Directeur Général	-
ALEXION PHARMACEUTICALS, INC.	Directeur Technique/Scientifique/R&D	-
Enobia Pharma, Inc.	Conseiller Juridique Général	-
Biotechnica International, Inc.	Corporate Officer/Principal	-